 |
|
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651. Published online 2020 Oct 1 DOI: https://doi.org/10.3350/cmh.2020.0196
|
|
Citations to this article as recorded by
 Prospective study on time-to-tertiary care in alcohol-associated hepatitis: space–time coordinates as prognostic tool and therapeutic target
Ľubomír Skladaný, Daniela Žilinčanová, Natália Kubánek, Svetlana Adamcová Selčanová, Daniel Havaj, Lukáš Laffers, Michal Žilinčan, Alvi H Islam, Juan Pablo Arab, Tomáš Koller
Alcohol and Alcoholism.2025;[Epub] CrossRef Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis
Ankur Jindal, Manoj K. Sharma, Rajan Vijayaraghavan, Shasthry SM, Guresh Kumar, Shiv K. Sarin
Digestive Diseases and Sciences.2024; 69(1): 298. CrossRef Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes
Ana-Maria Singeap, Horia Minea, Oana Petrea, Madalina-Andreea Robea, Ioana-Miruna Balmuș, Raluca Duta, Ovidiu-Dumitru Ilie, Carmen Diana Cimpoesu, Carol Stanciu, Anca Trifan
Medicina.2024; 60(2): 311. CrossRef Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis
Marcus A. Healey, Geetha Ramalingam, Yiwei Hang, Ekaterina Smirnova, Amon Asgharpour, Vaishali Patel, Hannah Lee, Velimir Luketic, Scott Matherly, Mohammad Siddiqui, Joel Wedd, Arun Sanyal, Richard K. Sterling
Digestive Diseases and Sciences.2024; 69(8): 3043. CrossRef Quercetin alleviates ethanol‐induced hepatic steatosis in L02 cells by activating TFEB translocation to compensate for inadequate autophagy
Xingtao Zhao, Xinyan Xue, Jing Wang, Shu Dai, Cheng Peng, Yunxia Li
Phytotherapy Research.2023; 37(1): 62. CrossRef Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis
Lukas Van Melkebeke, Annelotte G. C. Broekhoven, Tessa Ostyn, Hannelie Korf, Minneke J. Coenraad, Roman Vangoitsenhoven, Bart Van der Schueren, Matthias Lannoo, Hannah Van Malenstein, Tania Roskams, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Obesity Surgery.2023; 33(1): 284. CrossRef AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Ashok Choudhury, Dong Joon kim, Ajit Sood, Omesh Goyal, Vandana Midha, Harshad Devarbhavi, Anil Arora, Ashish Kumar, Manoj Kumar Sahu, Sudhir Maharshi, Ajay Kumar Duseja, Virendra Singh, Sunil Taneja, P. N. Rao, A
Hepatology International.2023; 17(3): 662. CrossRef Management of alcoholic hepatitis: A clinical perspective
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, Münevver Demir
Liver International.2023; 43(10): 2078. CrossRef Efficiency of glucocorticosteroids in severe alcoholic hepatitis
A. S. Rodina, I. V. Kurbatova, M. E. Shubina, O. P. Dudanova
Meditsinskiy sovet = Medical Council.2023; (8): 135. CrossRef Past, Present, and Future Therapies for Alcohol-associated Hepatitis
Sally Condon, Loretta L. Jophlin
Clinical Therapeutics.2023; 45(12): 1171. CrossRef Mesenchymal stem cells-based therapy in liver diseases
Heng-Tong Han, Wei-Lin Jin, Xun Li
Molecular Biomedicine.2022;[Epub] CrossRef Can granulocyte colony stimulating factor (G-CSF) ameliorate acetaminophen-induced hepatotoxicity?
EA Ahmed, AM Abd-Eldayem, E Ahmed
Human & Experimental Toxicology.2021; 40(10): 1755. CrossRef Treatment of severe alcoholic hepatitis: A systematic review
Lukas Van Melkebeke, Hannelie Korf, Emmanuel A. Tsochatzis, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Current Opinion in Pharmacology.2021; 60: 91. CrossRef
|